Skip to main content
TipRanks
Go Ultimate75% OFF

Burning Rock Biotech (BNR) Stock Statistics & Valuation Metrics

94 Followers

Total Valuation

Burning Rock Biotech has a market cap or net worth of $139.79M. The enterprise value is $35.78M.

Market Cap
$139.79M
Enterprise Value
$35.78M

Share Statistics

Burning Rock Biotech has 8,813,858 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
8,813,858
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Burning Rock Biotech’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -9.28%.

Return on Equity (ROE)
-0.10
Return on Assets (ROA)
-0.07
Return on Invested Capital (ROIC)
-9.28%
Return on Capital Employed (ROCE)
-0.10
Revenue Per Employee
808.95K
Profits Per Employee
-82.98K
Employee Count
667
Asset Turnover
0.66
Inventory Turnover
2.40

Valuation Ratios

The current PE Ratio of Burning Rock Biotech is -1.38. Burning Rock Biotech’s PEG ratio is -0.04.

PE Ratio
-1.38
PS Ratio
0.19
PB Ratio
0.19
Price to FCF
-5.34
Price to Operating Cash Flow
-7.87
PEG Ratio
-0.04

Income Statement

In the last 12 months, Burning Rock Biotech had revenue of 539.57M and earned -55.35M in profits. Earnings per share was -49.60.

Revenue
539.57M
Gross Profit
402.91M
Operating Income
-54.84M
Pretax Income
-53.79M
Net Income
-55.35M
EBITDA
-32.00M
Earnings Per Share (EPS)
-49.60

Cash Flow

In the last 12 months, operating cash flow was -12.22M and capital expenditures -5.25M, giving a free cash flow of -17.47M billion.

Operating Cash Flow
-12.22M
Free Cash Flow
-17.47M
Free Cash Flow per Share
-16.09

Dividends & Yields

Burning Rock Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-18.68%
Earnings Yield
-70.68%

Stock Price Statistics

Beta
1.94
52-Week Price Change
17.40%
50-Day Moving Average
13.77
200-Day Moving Average
14.92
Relative Strength Index (RSI)
52.08
Average Volume (3m)
35.07K

Important Dates

Burning Rock Biotech upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).

Last Earnings Date
Sep 02, 2026
Next Earnings Date
Nov 17, 2026
Ex-Dividend Date
―

Financial Position

Burning Rock Biotech as a current ratio of 2.99, with Debt / Equity ratio of 8.06%

Current Ratio
2.99
Quick Ratio
2.76
Debt to Market Cap
0.01
Net Debt to EBITDA
13.70
Interest Coverage Ratio
-1828.17

Taxes

In the past 12 months, Burning Rock Biotech has paid 1.56M in taxes.

Income Tax
1.56M
Effective Tax Rate
-0.03

Enterprise Valuation

Burning Rock Biotech EV to EBITDA ratio is 6.64, with an EV/FCF ratio of 16.06.

EV to Sales
-0.56
EV to EBITDA
6.64
EV to Free Cash Flow
16.06
EV to Operating Cash Flow
22.96

Balance Sheet

Burning Rock Biotech has $419.26M in cash and marketable securities with $45.13M in debt, giving a net cash position of $374.13M billion.

Cash & Marketable Securities
$419.26M
Total Debt
$45.13M
Net Cash
$374.13M
Net Cash Per Share
$42.45
Tangible Book Value Per Share
$457.65

Margins

Gross margin is 74.55%, with operating margin of -12.99%, and net profit margin of -13.59%.

Gross Margin
74.55%
Operating Margin
-12.99%
Pretax Margin
-13.27%
Net Profit Margin
-13.59%
EBITDA Margin
-8.43%
EBIT Margin
-13.23%

Analyst Forecast

The average price target for Burning Rock Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-3.65%
EPS Growth Forecast
51.30%

Scores

Smart Score
3
AI Score
47